Obalon Engages Cowen to Explore Financial and Strategic Alternatives
Obalon will proceed in an orderly manner to identify and evaluate possible financial and strategic alternatives for the Company and their implications. No assurance can be given as to whether any particular financial or strategic alternative will be recommended or undertaken, and if so, upon what terms and conditions. Obalon does not intend to make any further public announcements regarding its review of possible financial and strategic alternatives until its Board of Directors has approved a transaction or otherwise determined that further disclosure is appropriate or required by law.
To the extent that statements contained in this press release are not descriptions of historical facts regarding
Chief Financial Officer
Office: +1 760 607 5103
Source: Obalon Therapeutics, Inc.